Actimab-B
N/A
Report date: 2025/11/04 16:07:39
Base Information
Drug NameActimab-B
Drug Alias Name
Classification +[4]
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFred Hutchinson Cancer Research Center
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesFred Hutchinson Cancer Research CenterActinium Pharmaceuticals Inc
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A